Saturday 17 October 2026 Export GILD’s income statement to Excel — free account

Gilead Sciences, Inc.

GILD Healthcare Drug Manufacturers General

Gilead Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $29.4 billion, up 2.40% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS fell 638.2%, free cash flow grew 376.8% and total debt rose 5.21%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for ten consecutive years.

156.19 1.18 −0.75%

Follow GILD

Alert me

Market cap: $195.1B
P/E: 0.0×
Fwd P/E: −46.2×
Dividend yield: 2.08%
F-score: 8/9
Altman Z: 4.03
Beneish M: −2.45
Dividend safety: 77/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(20.68%)	43.36%	40.66%	40.71%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	5	9	8	8
ROA Full definition →	(6.17%)	16.35%	14.42%	14.35%
ROIC Full definition →	(4.48%)	17.07%	15.69%	16.79%
Return on Tangible Assets Full definition →	(36.99%)	62.26%	70.13%	73.22%
Average Days of Receivables Full definition →	60.58	58.19	60.91	63.93
Free Cash Flow per Share Full definition →	10.41	8.24	7.60	7.37
Free Cash Flow Full definition →	12,943.00	10,230.00	9,456.00	9,162.00
Capital Expenditures Full definition →	(609.00)	(576.00)	(563.00)	(505.00)
Other line items
Cash ROIC Full definition →	31.44%	19.21%	17.13%	17.05%
Accounts Receivable Turnover Full definition →	6.19	6.51	6.31	6.01
Accounts Payable Turnover Full definition →	9.90	8.88	8.05	7.24
Inventory Turnover Full definition →	3.29	3.34	3.58	3.39
Average Days of Payables Full definition →	39.57	38.35	41.86	47.64
Days of Inventory on Hand Full definition →	114.66	113.80	103.87	105.24
Tax Rate Full definition →	0.66	(0.14)	(0.13)	(0.18)
Research and Development Expense of Revenue Full definition →	19.91%	19.48%	19.70%	20.14%
Selling, General and Administrative Expense of Revenue Full definition →	21.42%	20.07%	19.61%	20.24%
Share Based Compensation of Revenue Full definition →	2.98%	3.04%	3.04%	3.05%
Interest Coverage Full definition →	(2.51)	10.33	9.79	10.30
Operating CF/Net income Full definition →	(4.18)	1.17	1.18	1.19
Depreciation/Fixed assets Full definition →	0.47	0.49	0.49	0.50
Capex/Depreciation Full definition →	(0.22)	(0.21)	(0.20)	(0.18)
Revenue per Share Full definition →	24.50	23.94	23.67	23.40
Operating CF per Share Full definition →	10.90	8.70	8.05	7.78
Capex per Share Full definition →	(0.49)	(0.46)	(0.45)	(0.41)
Capex to Sales Full definition →	0.02	0.02	0.02	0.02

Show all line items

Columns are period end dates

Stockrow Weekly